Head And Neck Cancer

A Simplified Dose Schedule of Cetuximab as a Maintenance Therapy in Head and Neck Cancer May Reduce Drug Toxicities

A Simplified Dose Schedule of Cetuximab as a Maintenance Therapy in Head and Neck Cancer May Reduce Drug Toxicities

By

In a small group of head and neck cancer patients, biweekly doses of cetuximab in the maintenance setting appeared to be more tolerable than weekly doses.

Oncology Community Expresses Concern About Medicare Advantage Step-Therapy Policy

Oncology Community Expresses Concern About Medicare Advantage Step-Therapy Policy

By

More than 90 medical societies have called on the US government to reverse a policy allowing step therapy under Medicare Advantage.

FDA Guidance: Expansion Cohort Trials Expected to Modernize Oncology Trials

FDA Guidance: Expansion Cohort Trials Expected to Modernize Oncology Trials

By

There is a push to create innovative adaptive trial designs that include more patients and, subsequently, more generalizable data.

Bispecific Antibodies in Cancer

Bispecific Antibodies in Cancer

By

Interest in these bioengineered antibodies has been rekindled by the striking success seen in the treatment of some cancers with immunotherapies.

Novel Biomarker COX-2 May Have a Prognostic Role in Nasopharyngeal Carcinoma

Novel Biomarker COX-2 May Have a Prognostic Role in Nasopharyngeal Carcinoma

By

The biomarker may be a predictor of response to treatment and cancer progression in nasopharyngeal carcinoma.

Recreational Marijuana May Improve Quality of Life Outcomes in Head and Neck Cancer

Recreational Marijuana May Improve Quality of Life Outcomes in Head and Neck Cancer

By

Previous studies have demonstrated that patients with head and neck cancer experience high levels of stress, anxiety, and psychosocial distress throughout the course of the disease.

Cognitive Functioning Affects the Ability of Patients With Advanced Cancer to Give Informed Consent

Cognitive Functioning Affects the Ability of Patients With Advanced Cancer to Give Informed Consent

By

Approximately half of patients with advanced cancer who are enrolled in phase 1 clinical trials do not know the ultimate goal of the study.

Triclosan and Cancer Risk: Is There a Link?

Triclosan and Cancer Risk: Is There a Link?

By

Some studies suggest triclosan could have oncogenic properties, but more research is needed to confirm a causal link.

Pazopanib Plus Cetuximab May Be Effective and Well-Tolerated in Head and Neck Cancer

Pazopanib Plus Cetuximab May Be Effective and Well-Tolerated in Head and Neck Cancer

By

Only a few studies have investigated the effectiveness of pazopanib and cetuximab, an angiogenesis inhibitor and EGFR inhibitor, respectively, for head and neck squamous cell carcinoma.

Pembrolizumab May Lead to Favorable Long-Term Outcomes in Head and Neck Cancer

Pembrolizumab May Lead to Favorable Long-Term Outcomes in Head and Neck Cancer

By

The anti-programmed death 1 (PD-1) antibody pembrolizumab was determined to be an effective second-line option for patients with head and neck cancers.

Is Genomic Medicine Failing Minority Patients?

Is Genomic Medicine Failing Minority Patients?

By

Racial minorities are poorly represented in genomic research databases, raising important questions about whether or not all patients will benefit equally from advances in precision oncology.

Motolimod Combination Therapy Does Not Improve Survival in Squamous Cell Carcinoma of the Head and Neck

Motolimod Combination Therapy Does Not Improve Survival in Squamous Cell Carcinoma of the Head and Neck

By

Previous studies have demonstrated that motolimod can induce positive immune responses, but it did not improve outcomes in the first-line setting in squamous cell carcinoma of the head and neck in the featured study.

<i>ARID1A</i> Mutations Might Predict Tumor Response to Immunotherapy

ARID1A Mutations Might Predict Tumor Response to Immunotherapy

By

New findings bolster the case for the predictive utility of ARID1A mutations.

Liquid Biopsies and Cancer Detection: New Test Assesses Levels of Circulating Proteins for Early-Stage Diagnosis

Liquid Biopsies and Cancer Detection: New Test Assesses Levels of Circulating Proteins for Early-Stage Diagnosis

By

A new test has been shown to be capable of identifying eight different cancers by assessing levels of circulating proteins along with mutations in cell-free DNA.

Understanding Telomerase: Higher Quality Images Give Insight Into Developing New Agents for Inhibition

Understanding Telomerase: Higher Quality Images Give Insight Into Developing New Agents for Inhibition

By

Telomerase plays a crucial role in tumor proliferation, and a better understanding of its structure will pave the way for new drug development.

Efficacy and Hyperemesis Syndrome Associated With Cannabinoid Use in Cancers ― In the Clinic

Efficacy and Hyperemesis Syndrome Associated With Cannabinoid Use in Cancers ― In the Clinic

By

Many clinical trials and systematic reviews note that the use of cannabinoids also comes with adverse events, including a clinical entity that has been gaining evidence in the literature over the last decade called cannabinoid hyperemesis syndrome.

Nimotuzumab in Combination With Concurrent Radiotherapy and Cisplatin Is Active in Locally Advanced SCCHN

Nimotuzumab in Combination With Concurrent Radiotherapy and Cisplatin Is Active in Locally Advanced SCCHN

By

Nimotuzumab in combination with concurrent radiotherapy and cisplatin provides significant clinical benefits in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).

Women With Head and Neck Cancer Receive Less Treatment and Have Inferior Outcomes Compared With Men

Women With Head and Neck Cancer Receive Less Treatment and Have Inferior Outcomes Compared With Men

By

When variables such as age and serious medical conditions were accounted for cancer versus non-cancer mortality was two times higher for women compared with men.

Immune-Related Adverse Events During Anti-PD-1 Therapy May Increase Survival in Head and Neck Cancer

Immune-Related Adverse Events During Anti-PD-1 Therapy May Increase Survival in Head and Neck Cancer

By

It is believed that immune competence may modify anti-tumor response with anti-PD-1 therapy.

Quality-of-Life Outcomes for Pembrolizumab Compared With Standard of Care in Head and Neck Cancer

Quality-of-Life Outcomes for Pembrolizumab Compared With Standard of Care in Head and Neck Cancer

By

Two year treatment with pembrolizumab prolonged overall survival compared with standard of care among patients with HNSCC, but the effects on quality of life require further elucidation.

Nivolumab Plus Cetuximab and Radiotherapy May Be a Safe Treatment Option in Head and Neck Cancer

Nivolumab Plus Cetuximab and Radiotherapy May Be a Safe Treatment Option in Head and Neck Cancer

By

Researchers sought to determine if the addition of nivolumab to radiotherapy and chemotherapy could improve outcomes among this patient population.

Nivolumab Plus Stereotactic Body Radiotherapy Fails To Improve Outcomes in Head and Neck Cancer

Nivolumab Plus Stereotactic Body Radiotherapy Fails To Improve Outcomes in Head and Neck Cancer

By

Although the addition of stereotactic body radiation therapy (SBRT) to nivolumab did not increase toxicity, it did not lead to any improvement in response rates or survival outcomes among patients with metastatic head and neck squamous cell carcinoma (HNSCC).

Can Oncolytic Viruses Improve Immunotherapies?

Can Oncolytic Viruses Improve Immunotherapies?

By

Emerging evidence shows that injecting tumors directly into one tumor can trigger systemic antitumor immunity and immune attacks on untreated tumors elsewhere in the body.

CYCORE System May Improve Radiotherapy-Associated Symptoms in Head and Neck Cancer

CYCORE System May Improve Radiotherapy-Associated Symptoms in Head and Neck Cancer

By

The CYCORE system may enable physicians to intervene at the early signs of dehydration and other radiotherapy-associated symptoms.

Head and Neck Cancers Treatment Regimens

Head and Neck Cancers Treatment Regimens

View detailed treatment regimens for head and neck cancers, with options such as cisplatin, cisplatin + radiotherapy, and more.

Noninvasive Exhaled Breath Test May Be Effective In Diagnosing Esophagogastric Cancers

Noninvasive Exhaled Breath Test May Be Effective In Diagnosing Esophagogastric Cancers

By

Oesophagogastro duodenoscopy is a diagnostic procedure to diagnose esophagogastric cancer, but is highly invasive and expensive.

Clonally Transmissible Cancers in Nature

Clonally Transmissible Cancers in Nature

By

While a recent discovery of a series of communicable cancers has raised concerns, there has been no sign of readily transmittable cancer in people that could spread through a population the way the ones found in other species do.

The Hunt for Effective Anticancer Vaccines

The Hunt for Effective Anticancer Vaccines

By

Researchers are hotly pursuing 2 distinct biological paths that show remarkable promise in the hunt for an effective anticancer vaccine.

Perioperative Gabapentin May Improve Pain Management in Head and Neck Cancer

Perioperative Gabapentin May Improve Pain Management in Head and Neck Cancer

By

The total morphine equivalents used were, however, not significantly different between arms.

ACA Decreased Non-Insurance Rates Among Patients With Head and Neck Cancer

ACA Decreased Non-Insurance Rates Among Patients With Head and Neck Cancer

By

These findings were, however, significant only in states that expanded Medicaid eligibility.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs